flow trial semaglutide all-cause mortality hazard ratio Relative risk of each individual MACE component as a function of CV Effects of Semaglutide on Chronic

Mitochondrial DNA integrity: role in health and disease

Efficacy and safety In clinical trials, patients taking retatrutide have shown an average weight loss reduction of up to 24% from baseline body weight

Using FDA-approved therapies like tirzepatide and semaglutide with close medical supervision, patients achieve meaningful, sustained weight loss and improved metabolic health

It is contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Researchers believe GLP-1s have an anti-inflammatory effect on tissues and immune cells

When they stop, its not just weight that comes back